Literature DB >> 31353841

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH.

Tzu-Fei Wang1, Jeffrey I Zwicker2, Cihan Ay3,4, Ingrid Pabinger3, Anna Falanga5,6, Darko Antic7, Simon Noble8, Alok A Khorana9, Marc Carrier10, Guy Meyer11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31353841      PMCID： PMC6773470          DOI： 10.1111/jth.14564

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  17 in total

1.  Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.

Authors:  J C Easaw; M A Shea-Budgell; C M J Wu; P M Czaykowski; J Kassis; B Kuehl; H J Lim; M MacNeil; D Martinusen; P A McFarlane; E Meek; O Moodley; S Shivakumar; V Tagalakis; S Welch; P Kavan
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

2.  Direct Oral Anticoagulants for Thromboprophylaxis in Ambulatory Patients with Cancer.

Authors:  Giancarlo Agnelli
Journal:  N Engl J Med       Date:  2019-02-21       Impact factor: 91.245

3.  Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH.

Authors:  A A Khorana; H-M Otten; J I Zwicker; G C Connolly; D F Bancel; I Pabinger
Journal:  J Thromb Haemost       Date:  2014-09-30       Impact factor: 5.824

4.  How I treat cancer-associated venous thromboembolism.

Authors:  Noémie Kraaijpoel; Marc Carrier
Journal:  Blood       Date:  2018-11-26       Impact factor: 22.113

5.  Prediction of venous thromboembolism in cancer patients.

Authors:  Cihan Ay; Daniela Dunkler; Christine Marosi; Alexandru-Laurentiu Chiriac; Rainer Vormittag; Ralph Simanek; Peter Quehenberger; Christoph Zielinski; Ingrid Pabinger
Journal:  Blood       Date:  2010-09-09       Impact factor: 22.113

6.  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Authors:  A A Khorana; C W Francis; E Culakova; N M Kuderer; G H Lyman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

7.  Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.

Authors:  Gary H Lyman; Kari Bohlke; Alok A Khorana; Nicole M Kuderer; Agnes Y Lee; Juan Ignacio Arcelus; Edward P Balaban; Jeffrey M Clarke; Christopher R Flowers; Charles W Francis; Leigh E Gates; Ajay K Kakkar; Nigel S Key; Mark N Levine; Howard A Liebman; Margaret A Tempero; Sandra L Wong; Mark R Somerfield; Anna Falanga
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

8.  Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.

Authors:  B J Carney; E J Uhlmann; M Puligandla; C Mantia; G M Weber; D S Neuberg; J I Zwicker
Journal:  J Thromb Haemost       Date:  2018-12-11       Impact factor: 5.824

9.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

10.  Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).

Authors:  Annie M Young; Andrea Marshall; Jenny Thirlwall; Oliver Chapman; Anand Lokare; Catherine Hill; Danielle Hale; Janet A Dunn; Gary H Lyman; Charles Hutchinson; Peter MacCallum; Ajay Kakkar; F D Richard Hobbs; Stavros Petrou; Jeremy Dale; Christopher J Poole; Anthony Maraveyas; Mark Levine
Journal:  J Clin Oncol       Date:  2018-05-10       Impact factor: 44.544
View more
  27 in total

Review 1.  Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Authors:  Hanny Al-Samkari; Jean M Connors
Journal:  Blood Adv       Date:  2019-11-26

2.  Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Authors:  Hanny Al-Samkari; Jean M Connors
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Prediction and Prevention of Cancer-Associated Thromboembolism.

Authors:  Alok A Khorana; Maria T DeSancho; Howard Liebman; Rachel Rosovsky; Jean M Connors; Jeffrey Zwicker
Journal:  Oncologist       Date:  2020-12-04

Review 4.  Update on Guidelines for the Management of Cancer-Associated Thrombosis.

Authors:  Michael B Streiff; Syed Ali Abutalib; Dominique Farge; Martina Murphy; Jean M Connors; Gregory Piazza
Journal:  Oncologist       Date:  2020-12-04

Review 5.  Challenging clinical scenarios for therapeutic anticoagulation: A practical approach.

Authors:  Kylee L Martens; Simone E Dekker; Megan Crowe; Thomas G DeLoughery; Joseph J Shatzel
Journal:  Thromb Res       Date:  2022-08-19       Impact factor: 10.407

6.  D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer.

Authors:  Vaibhav Kumar; Joseph R Shaw; Nigel S Key; Anton Ilich; Ranjeeta Mallick; Philip S Wells; Marc Carrier
Journal:  Oncologist       Date:  2020-10-12

7.  Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis.

Authors:  Floris T M Bosch; Frits I Mulder; Pieter Willem Kamphuisen; Saskia Middeldorp; Patrick M Bossuyt; Harry R Büller; Nick van Es
Journal:  Blood Adv       Date:  2020-10-27

8.  Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.

Authors:  Ryan Pelletier
Journal:  J Oncol Pharm Pract       Date:  2021-03-24       Impact factor: 1.809

9.  Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype.

Authors:  Maria Diaz; Jasmin Jo; Mark Smolkin; Sarah Jane Ratcliffe; David Schiff
Journal:  Neurology       Date:  2020-12-22       Impact factor: 9.910

Review 10.  Paraneoplastic Thromboembolism and Thrombophilia: Significance in Visceral Medicine.

Authors:  Christian Pfrepper
Journal:  Visc Med       Date:  2020-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.